Xylo Technologies Ltd. - Asset Resilience Ratio
Xylo Technologies Ltd. (XYLO) has an Asset Resilience Ratio of 15.76% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Xylo Technologies Ltd.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Xylo Technologies Ltd.'s Asset Resilience Ratio has changed over time. See Xylo Technologies Ltd. balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Xylo Technologies Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see XYLO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.92 Million | 15.76% |
| Total Liquid Assets | $5.92 Million | 15.76% |
Asset Resilience Insights
- Good Liquidity Position: Xylo Technologies Ltd. maintains a healthy 15.76% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Xylo Technologies Ltd. Industry Peers by Asset Resilience Ratio
Compare Xylo Technologies Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Xylo Technologies Ltd. (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Xylo Technologies Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.76% | $5.92 Million | $37.55 Million | +10.79pp |
| 2023-12-31 | 4.98% | $3.18 Million | $63.90 Million | -0.13pp |
| 2022-12-31 | 5.10% | $4.99 Million | $97.65 Million | -0.45pp |
| 2021-12-31 | 5.55% | $3.31 Million | $59.73 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $32.34 Million | -- |
| 2017-12-31 | 48.52% | $3.50 Million | $7.21 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more